Article
Effect of Infliximab on Gene Expression Profiling in Behçet's Disease
24 Aug 2011
Abstract excerpt
PURPOSE: Recent studies have demonstrated that a new anti-tumor necrosis factor (TNF)-α antibody, infliximab, is effective in controlling ocular inflammatory attacks in Behçet's disease. In this study, the effect of infliximab on gene expression patterns in peripheral blood mononuclear cells of Behçet's disease patients was investigated before and after initiation of infliximab treatment. METHODS: A human...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
